Purpose Amblyopia is a leading cause of vision impairment among children and young
adults. Individual studies showed significant variations in the prevalence of amblyopia in …

Amblyopia is a unilateral or, less often, bilateral reduction of best-corrected visual acuity
(BCVA) that usually occurs in the setting of an otherwise normal eye. It is a developmental …

Results from recent randomised clinical trials in amblyopia should change our approach to
screening for and treatment of amblyopia. Based on the current evidence, if one screening …

Objective: To compare 2 hours vs 6 hours of daily patching as treatments for moderate
amblyopia in children younger than 7 years. Methods: In a randomized multicenter (35 sites) …

Objective To compare patching and atropine as treatments for moderate amblyopia in
children younger than 7 years. Methods In a randomized clinical trial, 419 children younger …

OBJECTIVE: To compare full-time patching (all hours or all but 1 hour per day) to 6 hours of
patching per day, as prescribed treatments for severe amblyopia in children younger than 7 …

Amblyopia, defined as poor vision due to abnormal visual experience early in life, affects
approximately three per cent of the population and carries a projected lifetime risk of visual …

Amblyopia is a unilateral or, less often, bilateral reduction of best-corrected visual acuity
(BCVA) that usually occurs in the setting of an otherwise normal eye. It is a developmental …

Purpose The purpose of this review is to provide an update on current management and
recent research for amblyopia treatment. Part I will review patching, atropine penalization …

This review aims to disentangle cause and effect in the relationship between anisometropia
and amblyopia. Specifically, we examine the literature for evidence to support different …